Literature DB >> 6975596

The incidence and prevalence of reported multiple sclerosis.

H M Baum, B B Rothschild.   

Abstract

A national survey, sponsored by the National Institute of Neurological and Communicative Disorders and Stroke, to determine the incidence, prevalence, and economic impact of multiple sclerosis has just been completed. These data are the first report of the results. Based on the data gathered, it is estimated that on January 1, 1976, there were a reported 123,000 multiple sclerosis patients in the conterminous United States (a rate of 58 per 100,000). The annual incidence for the period 1970-1975 was estimated to be 8,800 (a rate of 4.2 per 100,000). The pattern of the disease being more common among females, whites, persons aged 30-50 years, and individuals living above the 37th parallel was also demonstrated. In addition to demographic characteristics, selected disease characteristics of the incidence and prevalence populations were also examined.

Entities:  

Mesh:

Year:  1981        PMID: 6975596     DOI: 10.1002/ana.410100504

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

1.  Migration and multiple sclerosis in Alaskan military veterans.

Authors:  Mitchell T Wallin; William F Page; John F Kurtzke
Journal:  J Neurol       Date:  2009-04-18       Impact factor: 4.849

Review 2.  Multiple sclerosis in the elderly patient.

Authors:  Amer Awad; Olaf Stüve
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

3.  Effects of sex steroids on immunoglobulin M production by Epstein-Barr virus-transformed B-cell line SKW6-CL4.

Authors:  H Mori; M Sawairi; N Itoh; T Hanabayashi; T Tamaya
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-12

4.  Incidence of multiple sclerosis: a periodic or stable phenomenon.

Authors:  H Meyer-Rienecker; F Buddenhagen
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

5.  Using the international classification of functioning, disability and health to expand understanding of paralysis in the United States through improved surveillance.

Authors:  Michael H Fox; Gloria L Krahn; Lisa B Sinclair; Anthony Cahill
Journal:  Disabil Health J       Date:  2015-03-14       Impact factor: 2.554

6.  Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.

Authors:  R S Prakash; E M Snook; J M Lewis; R W Motl; A F Kramer
Journal:  Mult Scler       Date:  2008-08-13       Impact factor: 6.312

Review 7.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

8.  Multiple sclerosis prevalence in the United States commercially insured population.

Authors:  Piyameth Dilokthornsakul; Robert J Valuck; Kavita V Nair; John R Corboy; Richard R Allen; Jonathan D Campbell
Journal:  Neurology       Date:  2016-02-17       Impact factor: 9.910

9.  Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk.

Authors:  Zongqi Xia; Charles C White; Emily K Owen; Alina Von Korff; Sarah R Clarkson; Cristin A McCabe; Maria Cimpean; Phoebe A Winn; Ashley Hoesing; Sonya U Steele; Irene C M Cortese; Tanuja Chitnis; Howard L Weiner; Daniel S Reich; Lori B Chibnik; Philip L De Jager
Journal:  Ann Neurol       Date:  2015-12-09       Impact factor: 10.422

10.  The prevalence of multiple sclerosis in 3 US communities.

Authors:  Curtis W Noonan; Dhelia M Williamson; Judy P Henry; Robert Indian; Sharon G Lynch; John S Neuberger; Randolph Schiffer; Janine Trottier; Laurie Wagner; Ruth Ann Marrie
Journal:  Prev Chronic Dis       Date:  2009-12-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.